Lidocaine ophthalmic Pregnancy and Breastfeeding Warnings
Lidocaine ophthalmic is also known as: Akten
Lidocaine ophthalmic Pregnancy Warnings
This drug should be used during pregnancy only if clearly needed.
US FDA pregnancy category: B
Animal studies failed to reveal evidence of fetal harm when this drug was administered subcutaneously at doses more than 800-fold greater than the human dose, based on body weight. There are no controlled data in human pregnancy.
US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
Lidocaine ophthalmic Breastfeeding Warnings
Caution is recommended.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments:
-This drug is secreted in human milk following systemic use; while no systemic exposure is expected with the ophthalmic formulation, caution is advised.
-The effects in the nursing infant are unknown.
References for pregnancy information
- "Product Information. Akten (lidocaine ophthalmic)." Akorn Inc, Buffalo Grove, IL.
References for breastfeeding information
- "Product Information. Akten (lidocaine ophthalmic)." Akorn Inc, Buffalo Grove, IL.
See Also...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
